Almea 2 Segregated Portfolio Co. Allergan plc 38.5(b) (3532M)
11 5월 2020 - 3:00PM
UK Regulatory
TIDM0Y7T
RNS Number : 3532M
Almea 2 Segregated Portfolio Co.
08 May 2020
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal Almea 2 Segregated Portfolio
trader Company
Company dealt in Allergan plc
============================
Class of relevant security Ordinary Shares
to which the dealings
being disclosed relate
(Note 1)
============================
Date of dealing 7 May 2020
============================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 2)
Long Short
Number (%) Number (%)
========== ====== =========== ======
(1) Relevant securities 4,006 0.00%
================== ===================
(2) Derivatives (other
than options)
================== ===================
(3) Options and agreements
to purchase/sell
================== ===================
Total 4,006 0.00%
================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(USD)
(Note 4)
Sell 438 193.6117
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 5) securities unit
e.g. CFD (Note 6) (Note 4)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 4)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
4)
(d) Other dealings (including transactions in respect of new
securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable)
(Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or
future acquisition or disposal of any relevant
securities to which any derivative
referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) NO
Date of disclosure 8 May 2020
Contact name Alwyn Basch
=============================
Telephone number 020 7742 7407
=============================
Name of offeree/offeror Allergan plc
with which connected
=============================
Nature of connection (Note Financial Advisor to Allergan
9) plc
=============================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEAPMMTMTTMBFM
(END) Dow Jones Newswires
May 11, 2020 02:00 ET (06:00 GMT)
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
